Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database.

@article{Weng2015EfficacyOA,
  title={Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database.},
  author={Jianping Weng and Sidartawan Soegondo and Oliver Schnell and Wayne H-H. Sheu and Władysław Grzeszczak and Hirotaka Watada and Noriyuki Yamamoto and S. Harshneet Kalra},
  journal={Diabetes/metabolism research and reviews},
  year={2015},
  volume={31 2},
  pages={155-67}
}
BACKGROUND Alpha-glucosidase inhibitors are recommended in some international guidelines as first-line, second-line and third-line treatment options but are not used worldwide due to perceived greater effectiveness in Asians than Caucasians. METHODS Data from ten post-marketing non-interventional studies using acarbose, the most widely used alpha-glucosidase inhibitor, from 21 countries, provinces and country groups were pooled. Effects on glycated hemoglobin (HbA1c ) were analysed for four… CONTINUE READING
4 Citations
16 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Diabetes Res Clin Pract 2013;102:16-24

  • JS Wang
  • 2013

Endocrine Pract 2013;19:327-36

  • AJ Garber
  • 2013

Diabetes Metab Syndr Obes 2012;5:357-67

  • C Rosak
  • 2012

Diabetes Metab Res Rev 2011;27:79-84

  • JS Wang
  • 2011

Diabetes Res Clin Pract 2011;92:312-21

  • WH Sheu
  • 2011

Diabetes Care 2007;30:263-9

  • L Monnier
  • 2007

Diabetes Care 2003;26:269-73

  • P Phillips
  • 2003

Diabetes Care 2003;26:881-5

  • L Monnier
  • 2003

Journal of the ASEAN Federation of Endocrine Societies 2003;21:24-31

  • AR Sumual
  • 2003

Diabetes Res Clin Pract 2000;50:49–56

  • S Halimi
  • 2000

Similar Papers

Loading similar papers…